Education and Training
An Observational Study of Hepatitis C Virus in Pregnancy
This multi-center observational study examines risk factors for HCV transmission from mother to baby.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
1. Singleton pregnancy
2. An HCV antibody positive screen (case) measured using two FDA-approved ELISA tests,
the Abbott Architect version 3.0 system and the Ortho HCV 3.0.
3. Gestational age at screening no later than 23 weeks and 6 days, and gestational age at
enrollment no later than 27 weeks and 6 days, based on clinical information and
evaluation of the earliest ultrasound as described below.
Exclusion Criteria:
1. Planned termination of pregnancy
2. Known major fetal anomalies or demise
3. Intention of the patient or the managing obstetricians for the delivery to be outside
a MFMU Network center, unless special provisions are made to insure infant follow-up
at two and 18 months of age.
4. Participation in this study in a previous pregnancy.
5. Unwilling or unable to commit to 18 months of follow-up for HCV positive infants
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Cynthia Willson, RN, BSN
650-724-6372
I'm interested